Methods of assessing HIV integrase inhibitor therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 13, 2007
Grant Date -
Feb 9, 2006
app pub date -
Aug 15, 2005
filing date -
Aug 8, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to methods and products for the evaluation of HIV treatment. The methods are based on evaluating molecular events at the HIV integrase resulting in altered therapeutic efficacy of the investigated compounds. The methods rely on providing an integrase gene and evaluating either through genotyping or phenotyping the integrase gene. The present invention relates to the fields of diagnostics, drug screening, pharmacogenetics and drug development.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully